ClinicalTrials.Veeva

Menu

BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

Roche logo

Roche

Status

Completed

Conditions

Colorectal Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT01791140
ML25630

Details and patient eligibility

About

This observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in combination with fluoropyrimidine-based chemotherapy in elderly patients (>/= 65 years of age) with newly diagnosed metastatic colorectal cancer. Patients will be followed until disease progression, death, withdrawal of consent, discontinuation of physician-patient relationship or study closure, whichever comes first.

Enrollment

3 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients, >/= 65 years of age
  • Patients with newly diagnosed metastatic colorectal cancer starting first-line treatment with Avastin in combination with fluoropyrimidine-based chemotherapy according to the approved Hungarian Summary of Product Characteristics
  • Patients suitable for Avastin treatment as assessed by the treating physician

Exclusion criteria

  • Any contraindications to Avastin treatment according to the Hungarian Summary of Product Characteristics

Trial design

3 participants in 1 patient group

Cohort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems